CompletedNot applicableNCT01946360

Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).

Studying Acute liver failure

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Liver and Biliary Sciences, India
Principal Investigator
Dr Ashok Choudhary, DM
Institute of Liver & Biliary Sciences.
Intervention
Methacetin Breath Test in ACLF and ALF patients(device)
Enrollment
24 enrolled
Eligibility
18-70 years · All sexes
Timeline
20142015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01946360 on ClinicalTrials.gov

Other trials for Acute liver failure

Additional recruiting or active studies for the same condition.

See all trials for Acute liver failure

← Back to all trials